Evaluation of immune responses engendered in CEA transgenic mice by a vaccine formulation composed of a recombinant CEA N domain antigen and advanced adjuvant.
Investors 1
| Date | Name | Website |
| - | Fight Agai... | facit.ca |
Mentions in press and media 16
| Date | Title | Description | Category | Author | Source |
| 07.08.2019 | BlueDot an... | Toronto-based healthtech start... | - | - | betakit.co... |
| 15.02.2017 | QD Solar S... | QD Solar, a Toronto, Canada-ba... | Canada | - | finsmes.co... |
| 17.01.2017 | Fibrocor T... | Fibrocor Therapeutics, LP, a T... | Canada | - | finsmes.co... |
| 19.02.2015 | eQOL recei... | MaRS Innovation is reporting t... | - | - | betakit.co... |
| 04.12.2014 | Big data b... | Among Horizon’s other investme... | - | - | medcitynew... |
| 03.12.2014 | Today in f... | Today was a big day in Toronto... | - | - | betakit.co... |
| 01.10.2014 | Lumira mak... | SOURCE: MaRS Innovation TORON... | - | - | lumiravent... |
| 30.07.2014 | Jefferson ... | This September, the newly form... | - | - | edsurge.co... |
| 12.02.2014 | Reflection... | That whole “not getting in fro... | - | - | medcitynew... |
| 27.01.2014 | The Accele... | The Accelerator Series is a mu... | - | - | betakit.co... |
Show more